A novel recurrent AML1-ETO fusion: Tight in vivo association with BCR-ABL1

Leukemia

Volumn 27, Issue 6, 2013, Pages 1397-1400

  Solari, L ^a   Bauer, T ^a   Dicker, F ^b   Haferlach, C ^b   Griesshammer M ^c   Schnittger, S ^b   Becker, H ^a   Lubbert M ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b MLL MUNICH LEUKEMIA LABORATORY   (Germany)

^c KLINIKUM MINDEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; DASATINIB; IMATINIB; NILOTINIB; TRANSCRIPTION FACTOR RUNX1;

ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; CANCER THERAPY; CASE REPORT; CHRONIC MYELOID LEUKEMIA; CLINICAL FEATURE; DISEASE ASSOCIATION; EOSINOPHIL; HUMAN; IN VIVO STUDY; LETTER; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; LEUKOCYTE; MALE; PRIORITY JOURNAL; PROMYELOCYTE; TREATMENT RESPONSE;

CORE BINDING FACTOR ALPHA 2 SUBUNIT; FUSION PROTEINS, BCR-ABL; HUMANS; KARYOTYPING; ONCOGENE PROTEINS, FUSION;

EID: 84878903530     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2013.53     Document Type: Letter

References (15)

1. Fabarius A, Leitner A, Hochhaus A, Mu ller MC, Hanfstein B, Haferlach C et al. Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML: long-term observation of 1151 patients from the randomized CML Study IV. Blood 2011; 118: 6760-6768.
2. Francesco D, Pasquali F. 8/21 translocation, loss of the Y chromosome and Philadelphia chromosome. Br J Haematol 1978; 38: 149-150. (Pubitemid 8281686)
3. Ferro MT, Steegman JL, Escribano L, Heiurichs B, Parada L, Garc?a-Sagredo JM et al. Ph-positive chronic myeloid leukemia with t(8;21)(q22;q22) in blastic crisis. Cancer Genet Cytogenet 1992; 58: 96-99.
4. de Greef GE, Hagemeijer A, Morgan R, Wijsman J, Hoefsloot LH, Sandberg AA et al. Identical fusion transcript associated with different breakpoints in the AML1 gene in simple and variant t(8;21) acute myeloid leukemia. Leukemia 1995; 9: 282-287.
5. Ohyashiki K, Ohyashiki JH, Iwama H, Hayashi S, Shay JW, Toyama K. Telomerase activity and cytogenetic changes in chronic myeloid leukemia with disease progression. Leukemia 1997; 11: 190-194. (Pubitemid 27085160)
6. Kojima K, Yasukawa M, Ishimaru F, Dansako H, Matsuo Y, Kimura Y et al. Additional translocation (8;21)(q22;q22) in a patient with Philadelphia-positive chronic myelogenous leukaemia in the blastic phase. Br J Haematol 1999; 106: 720-722. (Pubitemid 29434213)
7. Nucifora G, Birn DJ, Erickson P, Gao J, LeBeau MM, Drabkin HA et al. Detection of DNA rearrangements in the AML1 and ETO loci and of an AML1/ETO fusion mRNA in patients with t(8;21) acute myeloid leukemia. Blood 1993; 81: 883-888. (Pubitemid 23054821)
8. Zhang Y, Strissel P, Strick R, Chen J, Nucifora G, Le Beau MM et al. Genomic DNA breakpoints in AML1/RUNX1 and ETO cluster with topoisomerase II DNA cleavage and DNase I hypersensitive sites in t(8;21) leukemia. Proc Natl Acad Sci USA 2002; 99: 3070-3075. (Pubitemid 34240587)
9. Yin CC, Medeiros LJ, Glassman AB, Lin P. t(8;21)(q22;q22) in blast phase of chronic myelogenous leukemia. Am J Clin Pathol 2004; 121: 836-842. (Pubitemid 38669277)
10. Jabbour E, Kantarjian H, O'Brien S, Rios MB, Abruzzo L, Verstovsek S et al. Sudden blastic transformation in patients with chronic myeloid leukemia treated with imatinib mesylate. Blood 2006; 107: 480-482. (Pubitemid 43076368)
11. Hsiao HH, Tsai HJ, Liu YC, Lee CP, Lin SF. Allo-SCT in a rare t(8;21) evolution of CML. Bone Marrow Transplant 2010; 45: 1365-1366.
12. Najfeld V, Wisch N, Mascarenhas J, Issa L, Tripodi J, Sidhu M et al. Development of t(8;21) and RUNX1-RUNX1T1 in the Philadelphia-positive clone of a patient with chronic myelogenous leukemia: additional evidence for multiple steps involved in disease progression. Cancer Genet 2011; 204: 165-170.
13. Yin CC, Cortes J, Barkoh B, Hayes K, Kantarjian H, Jones D. t(3;21)(q26;q22) in myeloid leukemia: an aggressive syndrome of blast transformation associated with hydroxyurea or antimetabolite therapy. Cancer 2006; 106: 1730-1738.
14. Zhao X, Jankovic V, Gural A, Huang G, Pardanani A, Menendez S et al. Methylation of RUNX1 by PRMT1 abrogates SIN3A binding and potentiates its transcriptional activity. Genes Dev 2008; 22: 640-653. (Pubitemid 351342436)
15. Yan M, Kanbe E, Peterson LF, Boyapati A, Miao Y, Wang Y et al. A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesis. Nat Med 2006; 12: 945-949. (Pubitemid 44175147)